Steven Cohen Astrazeneca PLC Transaction History

Point72 Asset Management, L.P.

$40.1 Billion
Q1 2025

A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Astrazeneca PLC stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 1,187,672 shares of AZN stock, worth $86.3 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

1,187,672

Previous 1,187,672 -0.0%

Holding current value

$86.3 Million

Previous $87.3 Million -0.0%

% of portfolio

0.22%

Previous 0.22%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$65.37 - $77.96 $7.45 Million - $8.89 Million	114,042 Added 10.62%	1,187,672 $87.3 Million
Q4 2024 Feb 14, 2025	BUY	$63.2 - $79.58 $67.9 Million - $85.4 Million	1,073,630 New	1,073,630 $70.3 Million
Q2 2024 Aug 14, 2024	BUY	$66.81 - $80.83 $20.8 Million - $25.2 Million	311,550 Added 166.25%	498,950 $38.9 Million
Q1 2024 May 15, 2024	SELL	$61.03 - $69.57 $5.74 Million - $6.54 Million	-94,043 Reduced 33.41%	187,400 $12.7 Million
Q4 2023 Feb 14, 2024	BUY	$61.89 - $69.28 $17.4 Million - $19.5 Million	281,443 New	281,443 $19 Million
Q2 2023 Aug 14, 2023	BUY	$69.91 - $75.81 $23,000 - $24,941	329 New	329 $23,000
Q4 2022 Feb 14, 2023	SELL	$54.21 - $70.44 $177 Million - $230 Million	-3,272,170 Reduced 68.01%	1,539,490 $104 Million
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $151 Million - $385 Million	2,839,681 Added 144.0%	4,811,660 $264 Million
Q2 2022 Aug 15, 2022	BUY	$59.26 - $71.14 $37.8 Million - $45.4 Million	638,179 Added 47.85%	1,971,979 $130 Million
Q1 2022 May 16, 2022	SELL	$55.72 - $67.12 $24.3 Million - $29.2 Million	-435,600 Reduced 24.62%	1,333,800 $88.5 Million
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $36.2 Million - $42.7 Million	-669,688 Reduced 27.46%	1,769,400 $103 Million
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $35.3 Million - $38.6 Million	635,065 Added 35.2%	2,439,088 $146 Million
Q2 2021 Aug 16, 2021	SELL	$48.42 - $60.18 $84.7 Million - $105 Million	-1,748,824 Reduced 49.22%	1,804,023 $108 Million
Q1 2021 May 17, 2021	SELL	$47.16 - $54.44 $32.3 Million - $37.3 Million	-685,451 Reduced 16.17%	3,552,847 $177 Million
Q4 2020 Feb 16, 2021	BUY	$48.52 - $58.02 $182 Million - $218 Million	3,753,816 Added 774.81%	4,238,298 $212 Million
Q3 2020 Nov 16, 2020	SELL	$53.07 - $61.1 $11.2 Million - $12.9 Million	-210,906 Reduced 30.33%	484,482 $26.6 Million
Q2 2020 Aug 14, 2020	BUY	$43.1 - $55.31 $6.26 Million - $8.04 Million	145,339 Added 26.42%	695,388 $36.8 Million
Q1 2020 May 15, 2020	BUY	$37.79 - $51.33 $20.8 Million - $28.2 Million	550,049 New	550,049 $24.6 Million
Q3 2019 Nov 15, 2019	SELL	$40.12 - $45.47 $59.5 Million - $67.4 Million	-1,482,198 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$37.28 - $41.68 $32.6 Million - $36.5 Million	-875,724 Reduced 37.14%	1,482,198 $61.2 Million
Q1 2019 May 15, 2019	BUY	$35.49 - $43.02 $66.2 Million - $80.2 Million	1,865,364 Added 378.71%	2,357,922 $95.3 Million
Q4 2018 Feb 14, 2019	SELL	$36.86 - $41.49 $9.76 Million - $11 Million	-264,842 Reduced 34.97%	492,558 $18.7 Million
Q3 2018 Nov 14, 2018	SELL	$34.76 - $39.72 $71.1 Million - $81.2 Million	-2,044,646 Reduced 72.97%	757,400 $30 Million
Q2 2018 Aug 14, 2018	SELL	$34.55 - $37.05 $3.58 Million - $3.83 Million	-103,489 Reduced 3.56%	2,802,046 $98.4 Million
Q1 2018 May 15, 2018	BUY	$32.97 - $36.63 $65.3 Million - $72.5 Million	1,980,335 Added 214.04%	2,905,535 $102 Million
Q4 2017 Feb 14, 2018	SELL	$32.09 - $34.78 $9.62 Million - $10.4 Million	-299,739 Reduced 24.47%	925,200 $32.1 Million
Q3 2017 Nov 14, 2017	BUY	$28.96 - $34.0 $35.5 Million - $41.6 Million	1,224,939	1,224,939 $41.5 Million

Others Institutions Holding AZN

# of Institutions

1,430

Shares Held

507M

Call Options Held

10M

Put Options Held

3.14M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $225B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account